Literature DB >> 24836108

The gut microbiome, probiotics, bile acids axis, and human health.

Mitchell Lawrence Jones1, Catherine Tomaro-Duchesneau1, Satya Prakash2.   

Abstract

The human gut microbiome produces potent ligands to bile acid receptors, and probiotics could act as therapeutics of bile acid dysmetabolism. A recent study in Cell Reports demonstrates that probiotic VSL#3 affects bile acid deconjugation and excretion, as well as the gut-liver FXR-FGF15 axis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24836108     DOI： 10.1016/j.tim.2014.04.010

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  25 in total

Review 1.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

2.  Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.

Authors:  Vance L Albaugh; Charles Robb Flynn; Steven Cai; Yi Xiao; Robyn A Tamboli; Naji N Abumrad
Journal:  J Clin Endocrinol Metab       Date:  2015-07-21       Impact factor: 5.958

Review 3.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

Review 4.  The influence of the human microbiome and probiotics on cardiovascular health.

Authors:  Grace Ettinger; Kyle MacDonald; Gregor Reid; Jeremy P Burton
Journal:  Gut Microbes       Date:  2014

5.  Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation.

Authors:  S Banerjee; G Sindberg; F Wang; J Meng; U Sharma; L Zhang; P Dauer; C Chen; J Dalluge; T Johnson; S Roy
Journal:  Mucosal Immunol       Date:  2016-02-24       Impact factor: 7.313

6.  Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling.

Authors:  Suocheng Hui; Yang Liu; Li Huang; Lin Zheng; Min Zhou; Hedong Lang; Xiaolan Wang; Long Yi; Mantian Mi
Journal:  Int J Obes (Lond)       Date:  2020-03-17       Impact factor: 5.095

7.  Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model.

Authors:  Yanhong Li; Guiying Shi; Yunlin Han; Haiquan Shang; Huiwu Li; Wei Liang; Wenjie Zhao; Lin Bai; Chuan Qin
Journal:  Stem Cell Res Ther       Date:  2021-07-15       Impact factor: 6.832

8.  Preliminary probiotic and technological characterization of Pediococcus pentosaceus strain KID7 and in vivo assessment of its cholesterol-lowering activity.

Authors:  Karthiyaini Damodharan; Young Sil Lee; Sasikumar A Palaniyandi; Seung Hwan Yang; Joo-Won Suh
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

9.  Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.

Authors:  Ming-liang Chen; Long Yi; Yong Zhang; Xi Zhou; Li Ran; Jining Yang; Jun-dong Zhu; Qian-yong Zhang; Man-tian Mi
Journal:  MBio       Date:  2016-04-05       Impact factor: 7.867

Review 10.  A prospective view of animal and human Fasciolosis.

Authors:  K Cwiklinski; S M O'Neill; S Donnelly; J P Dalton
Journal:  Parasite Immunol       Date:  2016-07-08       Impact factor: 2.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.